Hemispherx BioPharma (HEB)

[JohnnyD3]

I'll agree that ridiculousness is the norm in gov't agencies. I think gov't agencies won't do anything until they are forced to. And that's really what the 17 expert letter, and HEB's move to raise the price for the first time since 1997 are all about - they are forcing the issue.

The 2012 FDA advisory committee voted 8 to 5 that ampligen is safe enough for commercialization. I think the large number of 200-400mg infusions show that it is well tolerated.

And more and more evidence that ampligen is a valuable drug for a variety of diseases. So maybe the FDA hates Carter because he was right? You've got to give him credit for hanging in there. We just need one more trial, using the NK cell data. It's clear HEB won't and cannot pay for a trial, so NIH will have to either cough up the cost or conditionally approve. Pressure is mounting.